<DOC>
	<DOC>NCT02257060</DOC>
	<brief_summary>The Linear II study is a prospective, single center, non-randomized, interventional feasibility study with the purpose of assessing acute safety of the Multi-Electrode Linear Type Ablation Catheter and the performance of the product when used for the treatment of symptomatic CTI (cavotricuspid isthmus) dependent right atrial flutter.</brief_summary>
	<brief_title>LINEAR II - LME-159 Evaluation of a Multi-Electrode Linear Type Ablation Catheter</brief_title>
	<detailed_description />
	<mesh_term>Atrial Flutter</mesh_term>
	<criteria>At least one symptomatic episode of typical CTI dependent right atrial flutter documented by 12 lead ECG, Holter monitor, transtelephonic event monitor, telemetry strip, or implanted device. Age 18 years or older. Previous typical CTI dependent right atrial flutter ablation Uncontrolled heart failure or NYHA function class IV MI within the past 2 months Any cardiac surgery (i.e. CABG) within the past 2 months Subjects that have ever undergone valvular cardiac surgical procedure (ie, ventriculotomy, atriotomy, and valve repair or replacement and presence of a prosthetic valve) Awaiting cardiac transplantation or other cardiac surgery within the next 6 months Documented thromboembolic event (including TIA) within the past 12 months Significant congenital anomaly or medical problem that in the opinion of the investigator would preclude enrollment in this study Active illness or active systemic infection or sepsis Unstable angina History of blood clotting or bleeding abnormalities Contraindication to anticoagulation (eg, heparin or warfarin) Life expectancy less than 6 months Presence of intracardiac thrombus, myxoma, interatrial baffle or patch, tumor or other abnormality that precludes catheter introduction or manipulation Presence of a condition that precludes vascular access Women of child bearing potential whom are pregnant, lactating, or planning to become pregnant during the course of the clinical investigation Currently enrolled in another device, biologics, or drug study Contraindication for use of the investigational catheter, as indicated in the respective Instructions For Use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Endocardial Ablation</keyword>
	<keyword>Atrial Flutter</keyword>
	<keyword>Cavotricuspid Isthmus</keyword>
</DOC>